The role of the hepatitis C virus glycoproteins in infection

Reviews in Medical Virology

Volumn 10, Issue 2, 2000, Pages 101-117

  Flint, Mike ^a,c   McKeating, Jane A ^a,b  

^a UNIVERSITY OF READING   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; HEPATITIS C VACCINE; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; NONHUMAN; REVIEW; VIRION; VIRUS CELL INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; HEPACIVIRUS; HEPATITIS C; HUMANS; MOLECULAR SEQUENCE DATA; VIRAL ENVELOPE PROTEINS;

EID: 0034023295     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1654(200003/04)10:2<101::AID-RMV268>3.0.CO;2-W     Document Type: Review

References (16)

1. Houghton M. Hepatitis C viruses. In Fields Virology, 3rd edn, Fields BN, Knipe DM, Howley PM, et al. (eds). Lippincott-Raven: Philadelphia, 1996; 1035-1058.
2. Rice CM. Flaviviridae: the viruses and their replication. In Fields Virology, 3rd edn, Fields BN, Knipe DM, Howley PM, et al. (eds). Lippincott-Raven: Philadelphia, 1996; 931-959.
3. Clarke B. Molecular virology of hepatitis C virus. J Gen Virol 1997; 78: 2397-2410.
4. Saito I, Miyamura T, Ohbayashi A, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A 1990; 87: 6547-6549.
5. Chen M, Sallberg M, Sonnerborg A, et al. Limited humoral immunity in hepatitis C virus infection. Gastroenterology 1999; 116: 135-143.
6. Mizutani T, Kato N, Saito S, Ikeda M, Sugiyama K, Shimotohno K. Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type-1 infected cell-line, MT-2. J Virol 1996; 70: 7219-7223.
7. Nakajima N, Hijikata M, Yoshikura H, Shimizu Y. K. Characterization of long-term cultures of hepatitis C virus. J Virol 1996; 70: 3325-3329.
8. Lohmann V, Korner F, Koch J-O, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999; 285: 110-113.
9. O'Connel JF. Mechanisms of action of interferon: potential role in hepatitis C. Viral Hepatitis Rev 1997; 3: 121-128.
10. Lindsay KL. Therapy of hepatitis C: overview. Hepatology 1997; 26: (Suppl), S71-S77.
11. Schalm SW, Weiland O, Hansen BE, et al. Interferon-ribavirin for chronic hepatitis C with and without cirrohosis: analysis of individual patient data of six controlled trials, Gastroenterology 1999; 117: 408-413.
12. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362.
13. Pileri P, Uematsu Y, Campagnoli S, et al. (1998). Binding of hepatitis C virus to CD81. Science 1998; 282: 938-941.
14. Hijikata M, Kato N, Ootsuyama Y, et al. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175: 220-228.
15. Weiner AJ, Geysen HM, Christopherson C, et al. Evidence for immune selection of hepatitis C virus putative envelope glycoprotein variants: potential role in chronic infection. Proc Natl Acad Sci U S A 1992; 89: 3468-3472.
16. Kato N, Sekiya Y, Ootsuyama Y, et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein of hepatitis C virus. J Virol 1993; 67: 3923-3930.